QUARTERLY REVIEW中文

Rocket Lab Q3 2026: backlog up 52% to $3.6 billion as Neutron slips into 2027

By · AI-assisted, human-reviewed and edited · · 8 sources · Fact-checked · 8 min read

Did the story change? Partly changed

Partly. Revenue of $267.8 million beat the top of Rocket Lab's own range, and backlog, its signed but unfinished contracts, rose 52% in three months to $3.57 billion. But Neutron, the larger rocket management has tied stand-alone adjusted profitability to, is now targeted to fly no earlier than 2027, and the net loss grew to $79.7 million, partly on costs of its pending Iridium purchase.

What it means

What changed
Backlog rose to $3.57 billion from $2.36 billion in a quarter, and Neutron's first launch moved from a hoped-for late 2026 into 2027.
What hasn't changed
Rocket Lab still loses money; on Nov 9 its finance chief again tied stand-alone adjusted profitability to Neutron's first successful launch.
Next · 2027
Neutron's first launch; Rocket Lab says it will give a more specific date after first-stage tests.

Closing prices: $62.71 on Nov 10, $58.86 on Nov 9 and $53.07 on Nov 6, 2026 (Nasdaq, Yahoo Finance).

Snapshot at the Nov 10, 2026 close

Market value
$39.6BIncluding the Series A preferred stock: $42.7B
Enterprise value
$34.9B
Price/sales
44.9×
EV/sales
39.6×
P/E
n/m
Revenue growth
+59%
Net cash
$4.7B

Our calculation from the company's filings (latest: 10-Q for the quarter to Sep 30, 2026, filed Nov 9, 2026); not investment advice. Revenue, earnings and cash flow: 12 months to Sep 30, 2026. Price $62.71 (Nasdaq historical close); 632.0 million shares (common shares on the cover page of the 10-Q filed Nov 9, 2026). n/m = not meaningful (e.g. negative earnings).

Rocket Lab’s sales beat its guidance, and its backlog grew. The setback is Neutron, its larger rocket: its first launch has moved into 2027, and management has said its stand-alone path to adjusted profitability runs through that launch.

How the stock reacted

Rocket Lab shares closed at $58.86 on Nov 9, up 10.9% from $53.07 on Nov 6, before the results, on a day when many space and chip stocks also rose (Yahoo Finance). After the results they fell 3.8% in after-hours trading, Investing.com reported. On Nov 10 they opened at $54.99, down 6.6%, and closed at $62.71, up 6.5% from Monday’s close of $58.86 (Nasdaq, Yahoo Finance).

Investing.com cited a consensus loss of 7 cents a share, without saying on what accounting basis; Rocket Lab’s loss under standard accounting rules (GAAP) was 12 cents a share. That loss included $27.3 million of financing costs and fees from ending an unused loan commitment for the Iridium deal, plus $21.3 million of transaction costs. Revenue beat the $257.2 million estimate Investing.com cited, and the midpoint of the fourth-quarter revenue guide, $280 million, was above the $265.5 million consensus it reported.

Did the story change?

In August Rocket Lab hoped to fly Neutron around the end of 2026; it now expects the first launch in 2027. The table compares Q2 with Q3.

Driver Q2 → Q3 2026 Management: before → now Signal
Revenue $234.1M → $267.8M (+14%; +73% from a year earlier) Q3 guide $250–265M (Aug 10) → delivered $267.8M; Q4 guide $270–290M Better
Backlog $2.36B → $3.57B (+52%); launch backlog $0.94B → $1.85B No backlog guidance → a record, Rocket Lab says Better
Gross margin (GAAP) 36.1% → 33.6% Q3 guide 29–31% (Aug 10) → above it; Q4 guide 34–36% Unchanged
Neutron first launch Not yet flown Pad delivery targeted for Q4 2026, year-end window “narrowing” (Aug 10 call) → launch in 2027 (Oct 14) Worse
Adjusted EBITDA −$8.8M → −$18.0M Q3 guide −$17M to −$23M → within it; Q4 guide −$14M to −$20M Unchanged

Sources: Q2 and Q3 releases and 10-Qs; the Aug 10 call (The Motley Fool’s transcript); the Oct 14 8-K. Adjusted EBITDA is the company’s measure of earnings before interest, taxes, depreciation, amortisation and other items it excludes. Comparisons are our calculations from reported figures.

Rocket Lab: revenue, gross margin and backlog by quarter

Revenue rose every quarter and backlog jumped in Q3 2026, while the GAAP gross margin dipped, as Rocket Lab had guided.

Revenue ($M)0100200300Q3 2025: $155.1MQ4 2025: $179.7MQ1 2026: $200.3MQ2 2026: $234.1MQ3 2026: $267.8MGAAP gross margin (%)3234363840Q3 2025: 37%Q4 2025: 38%Q1 2026: 38.2%Q2 2026: 36.1%Q3 2026: 33.6%Backlog at quarter end ($M)02,0004,000Q3 2025: $1,096MQ4 2025: $1,847.3MQ1 2026: $2,219.8MQ2 2026: $2,355.9MQ3 2026: $3,573MQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026Revenue ($M)0100200300Q3 2025: $155.1MQ4 2025: $179.7MQ1 2026: $200.3MQ2 2026: $234.1MQ3 2026: $267.8MGAAP gross margin (%)3234363840Q3 2025: 37%Q4 2025: 38%Q1 2026: 38.2%Q2 2026: 36.1%Q3 2026: 33.6%Backlog at quarter end ($M)02,0004,000Q3 2025: $1,096MQ4 2025: $1,847.3MQ1 2026: $2,219.8MQ2 2026: $2,355.9MQ3 2026: $3,573MQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q4 2025 is full-year 2025 less the first nine months. Gross margin is gross profit ÷ revenue, our calculation.

Rocket Lab results releases and 10-Q and 10-K filings, Q3 2025 to Q3 2026 (SEC).
Show the data table
Quarter Revenue ($M) GAAP gross margin (%) Backlog at quarter end ($M)
Q3 2025 155.1 37.0 1,096.0
Q4 2025 179.7 38.0 1,847.3
Q1 2026 200.3 38.2 2,219.8
Q2 2026 234.1 36.1 2,355.9
Q3 2026 267.8 33.6 3,573.0

What got better

Sales rose faster than guided. Space systems, which includes building whole satellites, brought in $214.8 million, up 88% from a year earlier, mainly from spacecraft manufacturing and acquisitions, the 10-Q says. Launch revenue rose 30% to $53.1 million, with six Electron launches against four a year earlier.

Contracts grew faster than revenue. Chief executive Peter Beck said nearly $1 billion of new launch contracts were signed in Q3 alone, and the launch backlog almost doubled in the quarter. Rocket Lab said it signed more than $515 million of Neutron contracts with satellite-network operators, giving the unflown rocket 16 booked missions, and lifted its base Neutron price to $70 million for several of them “as industry launch capacity tightens”. Part of the year’s backlog growth came from acquisitions, the 10-Q says.

Operating cash flow turned positive, at $7.2 million, against $134.4 million used in the first half. Changes in customer advances and deposits added about $66 million to it (our calculation from the cash flow statement). After $31.1 million of spending on equipment, cash flow was still negative, at about −$23.9 million.

The money for Iridium is in hand. Rocket Lab raised $3.91 billion through at-the-market share sales in the first nine months and ended September with $4.45 billion of cash. That includes $437.9 million it took early in September on forward share sales that run to April 2028, for which it issued 7.45 million shares as collateral. It says the purchase needs more than $3.0 billion of cash, and Iridium’s lenders agreed on Sep 15 to leave about $1.8 billion of Iridium’s loans in place, so the $3.6 billion bridge loan Rocket Lab had lined up was cancelled unused.

What needs watching

Neutron is late again. In February Rocket Lab moved the first launch to Q4 2026 after a first-stage tank burst in a January pressure test; in August Beck said the window for a year-end launch was “narrowing”. The 10-Q gives the cause of the latest slip: in October Rocket Lab found voids in part of a composite fuel-tank dome during manufacturing, and the filing said it needed to build a replacement dome, assemble the first-stage tank and finish pressure and cold-fuel tests before giving “a more specific launch timeline”. The release says the first launch is now targeted “no earlier than 2027”.

That matters for profit. On the Nov 9 call, chief financial officer Adam Spice said adjusted EBITDA would “turn positive within six months of that first successful test flight”, with cash flow following, and that “all of it hinges right now on Neutron”, according to Investing.com’s transcript. In August he had tied stand-alone adjusted EBITDA to the quarter after that flight (The Motley Fool’s transcript). He said Iridium, once the deal closes, brings “strong cash flow”. The Q4 guide is still an adjusted EBITDA loss of $14–20 million.

Less of the backlog is due soon. About 33% of the backlog is expected to become revenue within 12 months, against 45% at the end of June, according to the 10-Qs; in dollars that is about $1.2 billion, against about $1.1 billion (our calculation).

Spending ran above plan. Operating expenses were $169.3 million against a guide of $143–149 million, mostly because of $21.3 million of deal costs; excluding those, stock pay and amortisation, they were $130.2 million against a guide of $121–127 million.

More shares are out. Issued common shares rose to 680.1 million at Sep 30 from 589.5 million at the end of 2025, about 15% more, and Rocket Lab expects about 681 million weighted shares in Q4, including about 41 million preferred shares. Paying for Iridium will issue more shares on top.

The Iridium deal isn’t closed. Iridium’s shareholders approved it on Sep 24 and the US antitrust waiting period has expired, but it still needs FCC and some foreign approvals; Rocket Lab expects it to close in 2027, and in August Beck said “mid-2027”. After closing, Rocket Lab’s main operating subsidiary will guarantee Iridium’s loans, the 10-Q says.

On the Nov 9 call, Beck said the replacement dome had been made and cured and would go into assembly with the rest of the first-stage tank, followed by pressure tests at the factory and a cold-fuel test campaign at the launch site. Asked by Barclays analyst Anthony Valentini which month or quarter of 2027 Rocket Lab is aiming for, he declined to say: “I think if I provide a date, clearly, I’ve been wrong.” Spice said the dip in gross margin came mainly from the first full quarter of Mynaric, a laser-communications maker Rocket Lab bought, and from the absence of tariff refunds that helped Q2, and that he expects margins to improve in Q4 on a better business mix. Beck said Rocket Lab doesn’t need to raise more money to close the Iridium deal, and gave no closing date (Investing.com’s transcript).

Does this change the long-term story?

Our read: it changes the timing more than the direction. Sales beat Rocket Lab’s guidance and backlog grew, but the step management links to stand-alone adjusted profitability, Neutron’s first flight, has moved into 2027 with no specific date, and Iridium will reshape the company once the deal closes. Our Long View of Rocket Lab will be updated for this quarter.

Notes

  • Growth (our calculation): revenue $267.834M ÷ $234.066M − 1 = 14.4%; ÷ $155.080M − 1 = 72.7%. Backlog $3,573.0M ÷ $2,355.9M − 1 = 51.7%.
  • Gross margin (our calculation): Q3 2026 $90.071M ÷ $267.834M = 33.6%; Q2 2026 $84.576M ÷ $234.066M = 36.1%. Q4 2025: revenue $601.799M − $422.147M = $179.652M; gross profit $68.232M (Q4 release), 38.0%.
  • Q3 operating cash flow: −$127.254M (nine months) − (−$134.407M) (six months) = +$7.153M. Equipment and software purchases: $84.185M − $53.112M = $31.073M. Net operating cash-flow contribution from changes in contract liabilities: $144.485M − $78.835M = $65.650M.
  • Backlog due within 12 months (our calculation): 33% × $3,573.0M ≈ $1.18B; 45% × $2,355.9M ≈ $1.06B.
  • Shares: 680.1M issued ÷ 589.5M − 1 = 15.4%. Cash at Sep 30: $4,447.7M plus $256.2M of marketable securities.
  • Net loss per share: −$0.12 (basic and diluted, GAAP), against −$0.03 a year earlier.

What to watch next

After first-stage tests (no date given)
A specific Neutron launch date, which Rocket Lab says will follow a replacement tank dome and pressure and cold-fuel tests.
2027 (expected)
The Iridium purchase closing, which still needs US Federal Communications Commission (FCC) and some foreign approvals.
Early 2027 (expected)
Fourth-quarter results against the guide: revenue of $270–290 million and a GAAP gross margin of 34–36%.

Quick questions

What is backlog?

Revenue from signed contracts and orders that Rocket Lab hasn't earned yet, excluding unexercised options. Customers can usually cancel launch and spacecraft contracts by paying a fee.

What is Neutron?

Rocket Lab's larger rocket, designed to carry about 13,000 kg to low Earth orbit with a reusable first stage, far more than its small Electron rocket. It hasn't flown yet.

What is an at-the-market (ATM) offering?

A way for a company to sell new shares gradually into the market through banks, at market prices, instead of in one large sale.

About Rocket Lab: Website (external site)Investor relations (external site)SEC filings (external site)Wikipedia (external site)

Quoting this? You may quote short excerpts under our reuse policy. Please credit WhyMyStockMoved.com and link to this page.